바이오의약품 분석 시험 서비스 시장(2026-2030년)

The global biopharmaceutical analytical testing services market is forecasted to grow by USD 6347.3 mn during 2025-2030, accelerating at a CAGR of 15.5% during the forecast period. The report on the global biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing strategic outsourcing by pharmaceutical and biotechnology companies, growing complexity of biologic drugs and expanding biopharmaceutical pipeline, stringent regulatory landscape and intensifying emphasis on quality and safety.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biopharmaceutical analytical testing services market is segmented as below:

By Service

• Bioanalytical
• Method development and validation
• Stability testing
• Others

By End-User

• Pharma and biotech companies
• CROs

By Type

• Physiochemical analysis
• Biological assays
• Microbial testing
• Environmental monitoring

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the increasing focus on analytical services for advanced therapy medicinal products (atmps) as one of the prime reasons driving the global biopharmaceutical analytical testing services market growth during the next few years. Also, integration of advanced analytical technologies and data analytics and evolution towards strategic partnerships and integrated service offerings will lead to sizable demand in the market.

The report on the global biopharmaceutical analytical testing services market covers the following areas:

• Global biopharmaceutical analytical testing services market sizing
• Global biopharmaceutical analytical testing services market forecast
• Global biopharmaceutical analytical testing services market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biopharmaceutical analytical testing services market vendors that include Almac Group Ltd., Catalent Inc., Charles River Laboratories, Element Materials Tech., Eurofins Scientific SE, ICON plc, Intertek Group Plc, IQVIA Holdings Inc., Laboratory Corp., Lonza Group Ltd., Merck KGaA, Parexel International Corp., Sartorius AG, SGS SA, Syneos Health, Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd.. Also, the global biopharmaceutical analytical testing services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biopharmaceutical Analytical Testing Services Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biopharmaceutical Analytical Testing Services Market 2020 - 2024 ($ million)
• 5.2 Service segment analysis 2020 - 2024
  • Historic Market Size - Service Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on global biopharmaceutical analytical testing services market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Service

• 8.1 Market segments
• 8.2 Comparison by Service
• 8.3 Bioanalytical - Market size and forecast 2025-2030
• 8.4 Method development and validation - Market size and forecast 2025-2030
• 8.5 Stability testing - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Service
  • Market opportunity by Service ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharma and biotech companies - Market size and forecast 2025-2030
• 9.4 CROs - Market size and forecast 2025-2030
• 9.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Type

• 10.1 Market segments
• 10.2 Comparison by Type
• 10.3 Physiochemical analysis - Market size and forecast 2025-2030
• 10.4 Biological assays - Market size and forecast 2025-2030
• 10.5 Microbial testing - Market size and forecast 2025-2030
• 10.6 Environmental monitoring - Market size and forecast 2025-2030
• 10.7 Market opportunity by Type
  • Market opportunity by Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing strategic outsourcing by pharmaceutical and biotechnology companies
  • Growing complexity of biologic drugs and expanding biopharmaceutical pipeline
  • Stringent regulatory landscape and intensifying emphasis on quality and safety
• 13.2 Market challenges
  • Acute shortage of skilled personnel and rising labor costs
  • High capital investment and rapid technological obsolescence
  • Intensifying pricing pressure and commoditization of standard services
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Increasing focus on analytical services for advanced therapy medicinal products (ATMPs)
  • Integration of advanced analytical technologies and data analytics
  • Evolution towards strategic partnerships and integrated service offerings

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Almac Group Ltd.
  • Almac Group Ltd. - Overview
  • Almac Group Ltd. - Product / Service
  • Almac Group Ltd. - Key offerings
  • SWOT
• 15.5 Catalent Inc.
  • Catalent Inc. - Overview
  • Catalent Inc. - Business segments
  • Catalent Inc. - Key offerings
  • Catalent Inc. - Segment focus
  • SWOT
• 15.6 Charles River Laboratories
  • Charles River Laboratories - Overview
  • Charles River Laboratories - Business segments
  • Charles River Laboratories - Key offerings
  • Charles River Laboratories - Segment focus
  • SWOT
• 15.7 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
  • SWOT
• 15.8 ICON plc
  • ICON plc - Overview
  • ICON plc - Product / Service
  • ICON plc - Key offerings
  • SWOT
• 15.9 Intertek Group Plc
  • Intertek Group Plc - Overview
  • Intertek Group Plc - Business segments
  • Intertek Group Plc - Key offerings
  • Intertek Group Plc - Segment focus
  • SWOT
• 15.10 IQVIA Holdings Inc.
  • IQVIA Holdings Inc. - Overview
  • IQVIA Holdings Inc. - Business segments
  • IQVIA Holdings Inc. - Key offerings
  • IQVIA Holdings Inc. - Segment focus
  • SWOT
• 15.11 Laboratory Corp.
  • Laboratory Corp. - Overview
  • Laboratory Corp. - Business segments
  • Laboratory Corp. - Key news
  • Laboratory Corp. - Key offerings
  • Laboratory Corp. - Segment focus
  • SWOT
• 15.12 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
• 15.13 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.14 Parexel International Corp.
  • Parexel International Corp. - Overview
  • Parexel International Corp. - Product / Service
  • Parexel International Corp. - Key offerings
  • SWOT
• 15.15 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key news
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.16 SGS SA
  • SGS SA - Overview
  • SGS SA - Business segments
  • SGS SA - Key offerings
  • SGS SA - Segment focus
  • SWOT
• 15.17 Syneos Health
  • Syneos Health - Overview
  • Syneos Health - Product / Service
  • Syneos Health - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations